[home]
[thesaurus]
Click Here to return To Results
A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
Arch Neurol 63:49-54, Reisberg,B.,et al, 2006
See this aricle in Pubmed
Article Abstract
These results extend previous findings that demonstrated the efficacy and safety of memantine in the treatment of patients with moderate to severe Alzheimer disease.
Related Tags
(click to filter results - removes previous filter)
Alzheimer's disease
Alzheimer's disease,treatment of
dementia,treatment of
memantine
NMDA antagonists
treatment of neurologic disorder
Click Here to return To Results